ONC

Market Tracker

$258.32
+2.68
(+1.05%)
9:40 pm
Next Earnings: (est.) n/a
  • ONC (Selected)

  • ONCR

    Oncorus, Inc.
  • ONCS

    OncoSec Medical Incorporated
  • ONCT

    Oncternal Therapeutics, Inc.
  • ONCY

    Oncolytics Biotech Inc.

ONC Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

ONC Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

ONC Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

ONC Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

ONC Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

ONC Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
06/20/2025 PUT $230.00 1 +1
08/15/2025 CALL $260.00 152 +1 +0.66%
05/16/2025 CALL $105.00 0 0
05/16/2025 CALL $110.00 2 0
05/16/2025 CALL $115.00 0 0
05/16/2025 CALL $120.00 0 0
11/21/2025 PUT $380.00 0 0
11/21/2025 PUT $390.00 0 0
11/21/2025 PUT $400.00 0 0
05/16/2025 CALL $220.00 22 -1 -4.35%
05/16/2025 CALL $240.00 5 -1 -16.67%
05/16/2025 PUT $240.00 6 -2 -25.00%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

ONC News

  • Why Summit Therapeutics Rocketed Double-Digits Today

    04/23 04:05 pm

    The Motley Fool

    Read more
  • Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025

    04/17 06:00 am

    GlobeNewswire Inc.

    Read more
  • BeiGene Discontinues Lung Cancer Drug Study After Interim Data Showed Limited Survival Benefit

    04/03 11:19 am

    Benzinga

    Read more
  • China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer

    03/04 09:37 am

    Benzinga

    Read more
  • Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

    03/03 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Zymeworks Announces Participation in Upcoming Investor Conferences

    02/25 07:00 am

    GlobeNewswire Inc.

    Read more
  • Alibaba, Super Micro Computer And XPeng Are Among Top 10 Large Cap Gainers Last Week (Feb 17-Feb 21): Are The Others In Your Portfolio?

    02/23 11:05 am

    Benzinga

    Read more
  • Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025

    02/13 07:00 am

    GlobeNewswire Inc.

    Read more
  • Indaptus Therapeutics Provides Year-End Review and Outlook for 2025

    01/08 09:00 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: